Ivan Wasserman Quoted in “What Can You Say in Weight Loss Claims? Experts Weigh In”
For a story reported by NutraIngredients’ Danielle Masterson, Ivan Wasserman discussed the burgeoning weight loss medication category and how comparing supplements to drugs could land companies in hot water.
Ivan stated, “In the weight management category, the biggest no-nos are claims for obesity or diabetes. Also, comparing your supplements to drugs intended to treat those diseases — for example, a claim like ‘nature’s Ozempic’ — will likely trigger a big fat warning letter.” Ivan also advised to proceed with caution when using testimonials, highlighted the need to understand the FTC’s endorsement and testimonial guidelines and cited a number of cases the FTC has brought against major commercial diet programs.
Read more of what Ivan covered with Danielle here.
